Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Glycomimetics Announced Initial Safety, Tolerability, And Pharmacokinetic Results From Phase 1A Study Of GMI-1687 In Healthy Volunteers, Meeting Its Primary And Secondary Endpoints With No Dose-Limiting Toxicities Or Safety Signals

Author: Benzinga Newsdesk | January 04, 2024 08:16am

Posted In: GLYC